Loading…

Abbott announced plans to build a new cardiovascular device manufacturing facility in Georgia, expected to be completed in 2028. This follows a $500 million investment in U.S. manufacturing and R&D announced in April 2025, creating 300 jobs.
“Our transfusion medicine, R&D, medical affairs and marketing teams have visited key organizations around the world to understand their pain points.”abbott.com
Summarized from public sources; check the original articles before acting on it.